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ASSOCIATION OF MEASURES OF MUSCLE DENSITY AND SNPs IN HOMOLOGS OF MUSCLE 
FUNCTION GENES IN C.ELEGANS 
Sevinc Alkan, M.S. 
                                                     University of Pittsburgh, 2012 
Sarcopenia, the loss of muscle mass and strength that occurs with aging, has a crucial role in 
development of frailty. Sarcopenia is recognized as one of the major public health problems affecting 
approximately 8-40% of individuals greater than age 60 years worldwide. Although sarcopenia and other 
muscle-related traits are heritable, the underlying genetic variation contributing to the development of 
sarcopenia is unclear.   Previously, researchers identified 18 genes that will delay the onset of 
sarcopenia in an animal model for aging, Caenorhabditis elegans (Kashyap, 2010), of which 14 have a 
human homolog and SNP genotypes that were assayed in individuals from the Health, Aging, and Body 
Composition Study (Health ABC). The primary aim of this thesis is to assess whether there is a 
relationship between >700 single nucleotide polymorphisms (SNPs) total in 27 genes [14 genes 
identified from C. elegans and 13 genes in the mevalonate and ubiquinone pathways] and six traits 
related to sarcopenia using data from the HealthABC cohort. The 6 outcome variables are isokinetic leg 
muscle maximum torque( KCTMAX), thigh muscle density(THMUSD), thigh intermuscular fat 
area(THIMF), total lean mass (TOTLEAN), total percent fat(TOTPF) and thigh total muscle area(THMUS). 
The European and African American cohort were analyzed separately. After adjusting for the effects of 
gender, age, and ancestry, single SNP: single trait association tests were performed.  Although no SNPs 
were statistically significant at the experiment-wide p-value (p< 0.00001), SNPs in the locus MAGOHB 
were associated with THIMF, THMUSD, and TOTPF in European Americans, whereas SNPs in CYP3A5 
were associated with these traits in African Americans (p<0.01 for all).  Furthermore, SNPs in GOLGA4 
(P<0.01) and RALGABP (P<0.001) were associated with TOTPF in African Americans, and SNPs in 
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RALGABP were also associated with THIMF and TOTLEAN in African Americans.  These results indicate 
that variation in some genes related to development of muscle-wasting in an animal model, C. elegans, 
may have pleiotropic effects on traits related to sarcopenia in older men and women.  Follow-up studies 
of variation in these genes could elucidate new biological pathways involved in development of 
sarcopenia. 
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1.0 BACKGROUND AND SIGNIFICANCE 
 
1.1 SARCOPENIA 
1.1.1 Public Health Significance of Sarcopenia  
Sarcopenia is characterized by a decline in muscle quantity and quality and it is also a progressive loss of 
muscle mass with advancing age (Evans, 1995). The prevalence of sarcopenia ranges from 8 to 40% of 
people over 60 years (Kan, 2009). Sarcopenia has a crucial role in the pathogenesis of frailty with 
advancing age (Morley, 2001). The decline in the muscle strength results in decreased mobility and 
increased mortality in older people (Janssen, 2002).  The consequences of sarcopenia are decreased 
energy expenditure, decreased insulin sensitivity, reduction in muscle mass and strength, and increased 
physical disability, falls, and mortality. Sarcopenia has emerged as a highly important public health 
problem recently, because sarcopenia is associated with other common diseases or health problems 
including airway diseases (Sermet-Gaudelus et al., 2003), sarcopenic obesity (Roubenoff, 2000, 2004), 
osteoporosis (Szulc et al., 2005), cardiovascular diseases (Giles et al., 2006), and physical disability 
(Janssen, 2006). The number of older people who have health problems related to sarcopenia continues 
to increase all over the world. As a result, the economic burden of the sarcopenia-related health-care 
cost is large, and the health-care costs associated with sarcopenia were estimated to be $18.5 billion 
dollars in 2000 (Jansssen et al., 2004). 
Age, race, and gender influence the prevalence of sarcopenia. In 1998 in the U.S., the 
prevalence of sarcopenia in men was as follows: 14% of men younger than 70 years, 20% of men 70-74 
years, 27% of men 75-80 years, and 53% of men older than 80 years (Baumgartner et al., 1998). 
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Likewise, the prevalence in women was also high:  25% of women younger than 70 years, 33% of women 
were 70-74 years, 36% of women aged 75-80 years, and 43% of women aged greater than 80 years had 
sarcopenia (Baumgartner et al., 1998). According to Iannuzzi-Sucich et al. (2002), the sarcopenia 
prevalence in Caucasians aged 65 years or older was 22.6% in women and 26.8% in men, whereas 
among Caucasians, aged 80 years or older, it was 31.0% in women and 52.9% in men.  On the other 
hand, French, Chinese and Mexican men and women have lower rates of sarcopenia compared to 
Caucasians, likely due to cultural effects. The prevalence of sarcopenia in Mexicans less than 70 years 
old was 13-24%, but greater than 50% among individuals over 80 years old (Baumgartner et al., 1998). 
The prevalence of sarcopenia in Chinese was low, 12.3% in men and 7.6% in women older than 70 years 
(Lau et al., 2005).Likewise the prevalence of sarcopenia in a French women group older than 80 years 
was also low and equaled  10.9%(Gillette-Guyenne et al., 2003). Thus, the prevalence of sarcopenia is 
high, and will become higher as the world-wide population ages. 
1.1.2 Definition of Sarcopenia  
I.H. Rosenberg gave the name sarcopenia, that comes from Greek roots, sarx(flesh) and penia(loss) 
which describes skeletal muscle loss (Vandervoort, 2002).There are many definitions of sarcopenia to 
date (Newman et al. 2003; Visser 2009). One definition is that an individual has sarcopenia if his/her gait 
speed less than 1m/s and his/her appendicular lean/fat mass ratio is less than two standard deviations 
below the mean of young adults (Evans 2010). The most common definition of sarcopenia is that the 
ratio of appendicular skeletal muscle mass to height squared is more than two standard deviations 
below the mean of young adults (Evans, 1997; Baumgartner et al., 1998). This definition of sarcopenia 
requires measurements obtained from dual-energy X-ray absorptiometry (DXA) methods. DXA has led to 
easy and cheap measurement of body composition and is a great tool for research on skeletal muscle 
mass.  
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The current diagnosis of sarcopenia requires a decrease in the whole body or appendicular fat-
free mass combined with poor physical functioning (Newman, 2003). The current sarcopenia cut points 
are an appendicular fat lean mass/ht2 ≤7.23 kg/m2 in men and ≤5.67 kg/m2
1.1.3 Risk factors of Sarcopenia  
 in women. 
Sarcopenia has a complex and multifactorial etiology. The etiology of sarcopenia changes with age. 
Between ages 20 and 40 years, as a result of a decline in physical activity and a type II muscle fiber size, 
the sprinting capacity becomes lower. Between ages 40 and 60 years, as a result of the rapid decline in 
the motor units, decline in physical activity and increase in body fat, there is a decline in aerobic capacity 
and muscle protein synthesis. At the ages of 60-70 years, the physical activity is very low and body fat is 
very high, thus the declines in muscle protein synthesis are huge. After the age of 70 years, there is a 
further reduction in physical activity that causes increased muscle protein breakdown. 
Skeletal muscle declines as a proportion of body mass with increasing age. At ages 21-30 years, 
skeletal muscle represents approximately 45% of total body mass, whereas among individuals greater 
than 70 years of age, skeletal muscle represents only 27% of total body mass (Tan and Culberson, 2003). 
Protein constitutes approximately 20% of muscle weight and myosin and actin are the major muscle 
proteins. There are three main muscle fiber categories including type I, type IIA and type IIX. Although 
type I fibers have slow contraction and high endurance, type IIX fibers have faster contraction and lower 
endurance. Type IIA fibers have faster contraction than type I fibers, whereas type IIA fibers have slower 
contraction than type IIX fibers (Barany 1967; Thomas et al. 2007). The muscle function depends on the 
proportions of type I, type IIA and type IIX fibers. There is a decline in the proportion of type IIA fiber in 
sarcopenia (Leger et al., 2008). 
As a result of human and laboratory animal studies, there is some evidence about the possible 
mechanisms of sarcopenia including, decrease in muscle self-repair ability (Collins et al. 2005), inactivity, 
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decreased protein intake, loss of α-motor neurons, hormonal changes, inflammatory effects (increased 
IL-6), altered caloric intake, and changes in muscle cell physiology. However, the main mechanism of 
sarcopenia is still unclear (Volpi, 2004, Greenlund, 2003). This lack of knowledge regarding mechanisms 
also limits the effective treatment of sarcopenia.  Thus, there is a need to develop new model systems 
to understand the mechanism of sarcopenia with subsequent follow-up studies in humans. Results from 
these studies could lead to the development of new pharmacological agents for the effective treatment 
of sarcopenia.  
1.1.4 Genetic determination of Sarcopenia  
Two most commonly studied sarcopenia-related phenotypes are muscle mass and muscle strength. 
Muscle mass and muscle strength have multiple factors that differ among individuals. Although the 
variation among individuals is mostly determined by genetic factors, the specific genes that control 
these phenotypes are mostly unknown (Tan et al., 2011). Whole body lean mass (LM), DXA-derived, is 
one of the most used indices for muscle mass (Kim et al.2004, 2006b). Fat-free mass (FFM) and muscle 
size (cross section area) are other commonly studied phenotypes that are related to sarcopenia. The 
heritability of body lean mass, fat-free mass and muscle size phenotypes is very high. The heritability of 
LM ranges from 52% to 80% (Deng et al., 2001; Hsu et al.2005). The genetic contributions of fat-free 
mass and muscle size are 45-65% (Abney et al, 2001) and 70-90% (Huygens et al., 2004c), respectively. 
Results of segregation analyses have identified several loci that influence variation in whole 
body lean mass (Rice et al., 1993). Segregation analyses in Chinese (Liu et al.2004a) and other 
populations (Borecki et al., 1998; Karasik and Kiel 2008; Lecomte et al.1997) have confirmed that there 
are many genes with moderate effects that determine variations in whole body lean mass. 
There is significant evidence that many traits related to muscle strength have high heritability 
(h2). The heritability of hand grip strength(GS), quadriceps strength(QS) and lower limb muscle 
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strength(LLMS) were estimated as 30-52%(Arden and Spector 1997;Frediriksen et al., 2002), 31-
78%(Thomis et al.,1998;Tiainen et al.,2004) and 42-64% (Frederiksen et al.,2002) based on twin studies. 
With particular relevance to sarcopenia are reports that older people have showed significant 
heritability for muscle-related traits (Frederiksen et al., 2002; Mikkola et al., 2009). According to Prior et 
al, the heritability of appendicular lean mass was 20% among individuals older than 45 years (Prior et al, 
2007). In addition, genes account for 14% of the variance in quadriceps strength and 31% of variance in 
knee extension strength (Tiainen et al., 2004). Furthermore, the change in muscle strength with older 
age is also heritable (Zhai et al, 2004). 
To further investigate genetic basis of sarcopenia and muscle-related traits, additional genetic 
studies have been performed, including whole-genome linkage studies in humans, quantitative trait loci 
mapping in animal models, DNA microarrays and microRNA studies, genome-wide association studies, 
and candidate gene association studies of sarcopenia and sarcopenia-related skeletal muscle 
phenotypes. The results of some of these studies are described below. 
As a result of genome-wide linkage search for genes associated with fat-free mass (FFM), three 
quantitative trait loci (QTLs) associated with FFM were detected (Chagnon et al. 2000). One QTL on 
chromosome 12 was linked to a CA repeat polymorphism within the insulin-like growth factor 1 receptor 
(IGF1R) gene(LOD=3.56). ); LOD scores greater than 3.0 and 2.5 are considered significant and suggestive 
evidence, respectively, for linkage to a QTL. The second QTL showed evidence for linkage to a QTL on 
chromosome 18 (LOD=3.58).The last QTL showed moderate evidence for linkage to QTL on chromosome 
7 (LOD=2.72) (Chagnon et al. 2000). Zha and colleagues performed a large-scale linkage study and 
reported evidence of a QTL on chromosome 5 (LOD=2.54) for lean mass (LM) (Zhao et al. 2007). In 
addition, the marker that had the highest LOD score (LOD=4.49) was located on chromosome 12q24.3 
near the IGF1 gene (Zhao et al. 2007).  
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There is only one linkage study performed on older people.  Investigators performed linkage 
analyses using 397 microsatellites genotypes in 217 twin pairs from the Finnish Twin Study who were 
66-75 years of age. They detected a significant linkage between knee extensor isometric strength and a 
QTL on chromosome 8 (Tiainen et al.2008). Candidate gene studies of possible associations with 
sarcopenia have included a limited number of genes and have only analyzed a few SNPs within these 
genes. The results of the candidate gene studies have reported inconsistent results, probably because of 
population stratification, ethnic variability, sample size differences and gender differences (Tan et 
al.,2002). 
The number of linkage studies for sarcopenia-related phenotypes is very low. Based on the 
results of two studies, only 7q21, 7q32, 7p15.3, 15p13, and 20q13 were significant (Tan et al.,2002). 
There are a few genes identified that are related to variation in skeletal strength or skeletal 
mass. Based on the results of two or more studies, the ACE, ACTN3, MSTN, CNTF and VDR genes have 
been found to be associated with skeletal strength and skeletal mass (Tan et al.,2002). The strong 
genetic contribution of MSTN gene to variation in skeletal muscle phenotypes was confirmed by 
association studies, linkage studies, and expression studies. The IGF1 and IL-6 are also potential 
significant genes that were supported by linkage and association studies. Identification of genes that 
influence sarcopenia-related phenotypes could lead to development of new pharmacological 
interventions (Tan et al., 2002). 
1.2 ANIMAL MODEL FOR MUSCLE LOSS: CAERNOHABDITIS ELEGANS 
The nematode C.elegans has become a powerful model system in several areas of biology in recent 
years (Baumeister, 2002). C. elegans has a variety of experimental advantages including (1) it can be 
easily and cheaply cultured in the lab, (2) it has a short life span, (3) it has a completely sequenced 
genome , and (4)  the ability to use RNA interference ( Timmons,1998). Under laboratory conditions, 
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worms develop from egg to adult in 3 days, and reproduce at 4 or 5 days. The adult C.elegans has 12 to 
18 days lifespan. C.elegans has also been used commonly for genetic studies of longevity (Glenn, 2004). 
Using genetic studies, investigators determined that longevity in C. elegans is regulated by genes 
involved in the insulin and insulin-like growth factor (IGF) signaling pathway (Kimura, 1997).  The Insulin-
like pathway includes the daf-2 gene that encodes a protein similar to vertebrate insulin and IGF-I 
receptors (Kimura et al., 1997; Kenyon et al., 1993). Insulin-like pathways are found to be evolutionarily 
conserved in C.elegans (Tatar et al., 2003). 
As in humans, C. elegans also develops sarcopenia that is characterized by muscle loss that 
starts in midlife, increases with advancing age, and results in decreased mobility (Herndon, 2002, Glenn 
2004). The sarcopenia observed during aging has significant effects on worms. Because of the structural 
changes in the muscles, there is decreased mobility in the affected worms (Herndon et al.2002). Worms 
at young ages have increased physical activity that includes sinusoidal swimming in the agar plate. With 
aging of worms, there is an obvious physical decline in the physical activity (Driscoll, 2002). The declines 
in the mobility of worms were irreversible (Herndon et al., 2002).The decreased mobility is due to 
disorganized myofibrils and decreased myosin filaments (Herndon, 2002). Sarcopenia does not only 
affect the mobility of worms, but it also a major predictor of mortality during aging (Herndon et al., 
2002).Investigators have shown that mutations in daf-2 and age-1, two genes that are known to extend 
lifespan, also can lead to protection of animals from declines in movement during aging (Duhon, 1995; 
Morris et al., 1996; Larsen et al., 1995). In addition, there was also a delay in the locomotory declines in 
C.elegans that live long (Huang et al., 2004). These daf-2 mutants not only showed increased longevity, 
they also showed increased resistance to oxidative stress, hypoxia, heat stress, heavy metals, and 
bacterial pathogens (Antebi, 2007). Herdon and colleagues reported that aging in C.elegans is associated 
with sarcopenia (Herndon et al., 2002). Other investigators reported that animals with specific 
mutations in daf-2 pathway are resistant to the development of sarcopenia (Duhon, 1995, Herndon, 
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2002, Glenn, 2004). Using RNA interference in muscle, Kashyap and colleagues subsequently identified 
18 genes which are required for the delay in the onset of sarcopenia in daf-2 mutations (Kashyap, 
2010).The identified genes included splicing factors, vacuolar sorting proteins, transcription factors, and 
metabolic enzymes.  
1.3 SPECIFIC AIMS 
The main aim of this study was to assess whether SNPs in total of 27 genes (including 14 that are human 
homologs of C.elegans muscle function genes and 13 that are mevalonate and ubiquinone pathway 
genes) influence muscle-related traits in the Health, Age and Body Composition (HealthABC)  cohort 
(details of this cohort are described below). The specific genes are listed in Table 3 below. I also analyzed 
data available on the following muscle-related traits include isokinetic leg muscle maximum torque 
(KCTMAX), thigh intermuscular fat area(THMUS), thigh total muscle density (THMUSD), thigh total 
muscle density (THMUSD), total lean mass (TOTLEAN,) and total percent fat (TOTPF).  
The following are the aims of this study: 
1. Perform  Single SNP-Single trait association using simple regression analysis 
2. Use a few bioinformatic methods, including linkage disequilibrium among the SNPs within 
the genes, to facilitate identification of possible functional SNPs. 
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2.0 SUBJECTS AND METHODS 
 
2.1 SUBJECTS 
I used data from the Health, Aging and Body Composition Study (HealthABC). Health ABC is a 
longitudinal study of elderly European American and African American men and women who were 
healthy at the initial visit. The major objective of the HealthABC study is to evaluate changes in body 
composition with increasing age. Another aim of the Health ABC study is to identify genes that influence 
variation in body composition among an older age group. Briefly, the HealthABC study population 
consists of 3,075 well-functioning people from both sexes, who were 70-79 years old at baseline. Data 
on similar numbers of each sex by ancestry group were available, although slightly more women 
(N=1584) than men (N=1491) were recruited (Table 1). Likewise, more European (N=1794) than African 
American (N=1281) subjects were recruited. Study subjects were recruited from Pittsburgh, 
Pennsylvania (N=1527) and Memphis, Tennessee (N=1548) in March 1997- July 1998. The University of 
Pittsburgh and University of Tennessee institutional review board approved the protocol and all 
participants gave informed consent. European Americans and African Americans were recruited from all 
eligible ages in Pittsburgh and Memphis. Height was measured by a stadiometer and weight was 
measured by a calibrated balance-beam scale. Subjects’ height and weight were measured while they 
were wearing a hospital gown and no shoes.  Body mass index was also one of the body composition 
measures. Intermuscular fat area of the left thigh and right thigh were measured by CT. Total lean body 
mass is measured by DXA (Goodpaster et al. 2006) and thigh muscle cross-sectional area are measured 
by computed tomography (CT). (Goodpaster et al.  2006).  
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The summary of phenotypes can be found in Table 2. Genotype data were available on a total of 
1737 SNPs across 14 genes which are human homologs of C. elegans muscle function genes and 13 
mevalonate and ubiquinone pathway genes. 
Table 1: HealthABC Characteristics 
 
 
RACE 
GENDER 
 Male Female Total 
White 939 855 1794 
Black 552 729 1281 
Total 1491 1584 3075 
 
 
2.2 PHENOTYPES EXAMINED IN THIS STUDY 
Sarcopenia is loss of muscle mass and strength and increased muscle fat infiltration. Isokinetic leg 
muscle maximum torque (KCTMAX) is a measure of muscle strength and TOTLEAN, THMUS, and 
THMUSD were used for assessing the muscle mass changes.  There is also an association between fat 
accumulation within skeletal muscle and muscle weakness (Goodpaster 2000), poor function, and 
increase in the mobility limitations (Visser 2002). Goodpaster previously reported that lower muscle 
attenuation values on computed tomography (CT), a marker of greater muscle fat content (Goodpaster 
2000) is associated with lower muscle strength and muscle quality (Goodpaster 2001). A higher 
intermuscular fat area (IMF) is associated with several conditions related to aging such as insulin 
resistance (Goodpaster 2000, Greco 2002, Albu 2005) and type 2 diabetes mellitus (Ohkawa 2005). IMF 
is also associated with age (Ohkawa 2005). Based on these findings we included thigh intermuscular fat 
area as one of our phenotypes. 
Goodpaster et al. reported that African American women from the HealthABC cohort had higher 
body fat and higher total body mass, and total fat mass than European American women (Goodpaster, 
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2009). African American men had a higher total thigh muscle area than European American men. 
Similarly, African American women had a higher total thigh muscle area than European American 
women (Goodpaster, 2009). 
Table 2: HealthABC summary of phenotypes across both sexes and ancestral groups 
       
       
 
Phenotypes examined in this study are; 
1. KCTMAX: isokinetic leg muscle maximum torque (NM): 80-40deg 
2. THIMF:  Mean of right and left thigh intermuscular fat area (cm sq) 
3. THMUS: Mean of right and left  thigh total muscle area (cm sq) 
4. THMUSD: Mean of right and left thigh total muscle density (HU) 
5. TOTLEAN: total lean (gm) 
6. TOTPF: total percent fat 
Phenotypes  Min 1st Median  Qu. Mean 3rd Max  Qu.     N 
KCTMAX(nm) 
 
12.30 
 
78.91 
 
100.60 
 
106.30 
 
132.40 
 
461.70       2646 
 
THIMF( cm sq) 
 
0.100 
 
6.048 
  
8.955 
 
10.310 
 
13.030 
 
91.250 
 
3011 
 
THMUS (cm sq) 
 
THMUSD (HU) 
47.77 
 
2.425 
89.93 
 
31.110 
109.00 
 
36.600 
111.40 
 
35.380 
130.50 
 
40.270 
226.20 
 
70.060 
3011 
 
3011 
 
TOTLEAN(gm) 
 
 
247.50 
 
 
406.60 
 
 
483.90 
 
 
89.50 
 
 
565.40 
 
 
839.80 
 
 
3075 
 
TOTPF (%) 
 
Weight (kg) 
 
Height(cm) 
13.10 
 
33.50 
 
1370 
28.90 
 
65.50 
 
1590 
34.60 
 
75.20 
 
1658 
34.99 
 
75.81 
 
1662 
41.20 
 
85.00 
 
1732 
56.00 
 
141.00 
 
2007 
 
 
3075 
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2.2 GENOTYPING AND IMPUTATION 
Whole genome genotyping of the HealthABC participants was performed by the Center for Inherited 
Disease Research (CIDR) using the Illumina Human 1M-Duo BeadChip system. The HapMap imputation 
and initial quality control was performed by Yongmei Liu and Kurt Lohman of Wake Forest University. 
The following quality control measures were implemented by the Wake Forest team: data on individual 
samples were removed from the data if the genotyping for the sample failed overall (<97% SNPs 
genotyped), if the chromosome sex did not match the reported sex or if the first-degree relatedness was 
detected using the single-nucleotide polymorphism (SNP) data. All data on specific SNPs were removed 
from the data file if the SNP had a minor allele frequency (MAF) ≤ 1%, was called with ≤97% success, or 
had a Hardy-Weinberg equilibrium (HWE) test p value ≤ 10-6
Imputation was performed using MACH 1.0.16 (Li et al. 2010b) and the HapMap II phased 
haplotypes (Frazer et al.2007) as the reference. Genotypes were available for 914,263 SNPs based on 
the HapMap Centre d’Étude du Polymorphisme Humain (CEPH) reference panel (rel. 22, b36). A total of 
2,543,887 genotyped and imputed autosomal SNPs were ultimately available for analysis as part of the 
“HapMap SNP” set. 
. A total of 1,151,215 autosomal SNPs were 
successfully genotyped in 1.663 European American individuals and were carried forward to imputation. 
Quality control protocols for genotyping in African Americans were identical to European 
Americans; samples were excluded for low call rate (<97% SNPs were genotyped), mismatch between 
reported and chromosomal sex, and first degree relatedness. 1,151,215 SNPs were successfully 
genotyped in 1,139 African American individuals. SNPs with an MAF > 1%, a call rate > 97% and a HWE 
test p value > 10-6 were used for imputation. A total of 3,021,329 SNPs were ultimately available for 
analysis in the African Americans. Imputation was performed by Yongmei Liu and Kurt Lohman at Wake 
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Forest University using MACH 1.0.16 ( Li et al.2010b) and the HapMap II phased haplotypes (Frazer et 
al.2007) as reference. 
For the single SNP-single trait association analysis whole genome genotyping data were 
available on 1794 European American and 1281 African Americans. I included all SNPs (both assayed an 
imputed) that were located within the 27 genes of interest, plus all SNPs that were within ±5kb of the 5’ 
and 3’ untranslated regions of the 27 genes. The number of assayed plus imputed SNPs available (for the 
27 gens of interest) was 736 for European Americans and 999 for African Americans. For the association 
analyses in the current study, SNPs with the minor allele frequencies less than 0.05 were excluded. After 
MAF less than 0.05 removals, there were 627 SNPs in European American and 778 SNPs in African 
Americans. The number of SNPs within each gene after removal of MAF and the results are given in 
Table 3. 
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Table 3: List of Candidate Genes (and number of SNPs for African Americans and European Americans) 
used in the current study 
 
 
African Americans 
Total number of  SNPs= 778 
European Americans 
Total number of SNPs =627 
ADCK3 45 41 
CFL2 6 5 
COQ2 15 12 
COQ3 24 23 
COQ4 7 4 
COQ5 17 16 
COQ6 26 24 
COQ7 11 9 
CYP3A5 24 8 
FDPS 7 7 
GOLGA4 64 35 
HMGCR 12 17 
IDI1 23 23 
JUP 22 18 
MAGOHB 62 46 
MVD 10 13 
MVK 27 32 
NPC1 47 40 
PDSS1 62 53 
PMVK 14 13 
RALGAPB 81 30 
SACM1L 74 73 
SLC27A4 6 5 
TBC1D24 9 9 
TBP 34 34 
TOP1 42 36 
VPS33A 13 12 
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2.3 STATISTICAL METHODS 
All statistical analyses were done using the R 2.11.1 [R Development Core Team 2008]. First, I analyzed 
the distribution of the six muscle-related traits to assess the outliers and deviations from normality.   If 
necessary, the traits were transformed to reduce non-normality and values that were ±4sd were 
removed prior to subsequent analyses. Next, I did linear regression analyses to identify the effects of 
significant covariates, such as age, and sex. Because unknown admixture among individuals can bias 
results of population-based association studies, I also included measures of admixture using principle 
components of admixture derived by the Wake Forest team.  Based on the results of these linear 
regression analyses, I removed the effects of significant covariates, including admixture. All subsequent 
analyses were performed using these residual, transformed traits. I also estimated correlation among 
traits using the residuals. Finally, because some of the genotypes contained imputed data, the genotype 
data was represented as “probable allele dosage”. In other words, the genotype score ranged from 0 – 
2. Single SNP-single trait analysis were done using PLINK (Whole genome association analysis toolset) 
1.07 (Purcell, 2010). To control for multiple testing, results were not considered to be statistically 
significant unless the p-value was approximately ≤ 5×10-5. Multiple testing is one of the most important 
concerns in association tests (Yongchao et al.2003). Single SNP-single trait association tests require 
many tests.  Bonferroni method correction is one of the methods to decrease the concerns about 
multiple testing (Simes 1996). In our study, we used 6 traits and approximately 1400 SNPs and we are 
performing 8400 tests. Thus, by chance, at p value 0.05, we expect 410 false positive results. If we 
adjusted for multiple testing in our association study, we would need a p value= 0.05/8400 which is 
approximately 5×10-5. With Bonferroni method, we reduced the number of false positives in our study. 
Effects of possibly significant SNPs on the traits were plotted using box and whiskers plots. Finally, for 
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genes with multiple, potentially significant SNPs, I used LocusZoom 1.1 (Pruim,2010) to assess the 
location of the significant SNPs and linkage disequilibrium among the SNPs. 
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3.0 RESULTS 
 
3.1 PHENOTYPE CHARACTERIZATION 
3.1.1 Distribution and outliers 
Statistical analyses were performed in R 2.11.1 [R Development Core Team 2008]. All 6 phenotypes 
underwent quality control procedures including transformations to normality and outlier removal. 
KCTMAX (Figure 1 and Figure 2 ). THMUS, THMUSD and TOTLEAN were transformed by square roots. 
TOTPF was not transformed. THIMF was transformed by natural logarithms (Figure 3 and Figure 4). 
Observations that were greater than four standard deviations from the mean were classified as outliers 
and were removed. Values that were ±4sd were removed prior to subsequent analyses. In the 
HealthABC cohort, only one observation was removed from THIMF, THMUSD and KCTMAX. No other 
observation was removed from THMUS, TOTLEAN, and TOTPF. 
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Figure 1: Histogram of KCTMAX                                            Figure 2: Histogram of sqrtKCTMAX 
 
 
                                   Figure 3: Histogram of THIMF                                                    Figure 4: Histogram of logTHIMF 
 
 
3.1.2 Effects of covariates 
We analyzed effect of covariates (age, sex, and measures of admixture) and they were included in the 
regression models (Table 4). To be conservative, including these results as well as information from the 
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literature (See Introduction), I removed the effects of age, sex, and admixture in European and African 
Americans separately. The characteristics of residuals are given in table 5 and 6. These residuals were 
used in all subsequent analyses. 
Table 4: Effects of covariates (beta-values) on the muscle-related traits in European and African 
Americans 
  KCTMAX 
sqrt (nm) 
TOTLEAN 
sqrt (gm) 
THIMF 
log (cm sq) 
THMUS 
Log (cm sq) 
THMUSD 
sqrt (HU) 
TOTPF 
(%) 
European 
Americans     
        
      Sex -0.704** -0.823** -0.034(NS) -0.789** -0.197** 0.705** 
      Age -0.130** -0.056(NS) -0.002(NS) -0.082** -0.089** -0.051(NS) 
      PC1 0.083** 0.064(NS) 0.159** -0.005(NS) -0.136** 0.051(NS) 
      PC2 -0.037** -0.001(NS) 0.010** -0.005(NS) -0.003** -0.017(NS) 
              
African 
Americans 
            
      Sex -0.613** -0.704** 0.160** -0.666** -0.314** 0.746** 
      Age -0.113** -0.100(NS) -0.039(NS) -0.134** -0.111** -0.062(NS) 
      PC1 -0.057 (NS) -0.102** -0.043(NS) -0.101** -0.040(NS) 0.093** 
      PC2 -0.029(NS) -0.055** -0.025(NS) -0.035** -0. 019(NS) 0.035** 
              
  ** p< 0.001 
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Table 5: Summary of residuals of transformed traits in European Americans 
 Min. 1st Median  Qu. Mean 3rd Max  Qu. 
SqrtKCTMAX(nm) -5.186 -0.739 0.095 0.00 0.802 9.600 
SqrtTOTLEAN(gm) -39.69 -9.47 -0.58 0.00 8.74 56.58 
LogTHIMF(cm sq) -2.67 -0.33 0.03 0.00 0.36 2.37 
LogTHMUS(cmsq) -2.59 -0.53 0.01 0.00 0.53 2.85 
SqrtTHMUSD(HU) -3.22 -0.31 0.04 0.00 0.39 2.57 
TOTPF (%) -1374 -228.3 -14.61 0.00 234.5 1477 
 
Table 6: Summary of residuals of transformed traits in African Americans 
 Min. 1st Median  Qu. Mean 3rd Max  Qu. 
SqrtKCTMAX(nm) -5.34 -0.84 0.14 0.00 0.96 4.50 
SqrtTOTLEAN(gm) -52.51 -9.62 -0.11 0.00 9.99 45.21 
LogTHIMF(cm sq) -4.45 -0.36 0.006 0.00 0.41 2.20 
LogTHMUS(cmsq) -4.13 -0.55 0.05 0.00 0.58 3.18 
SqrtTHMUSD(HU) -4.03 -0.34 0.05 0.00 0.42 1.41 
TOTPF (%) -1365 -262.4 -6.59 0.00 235.4 1323 
 
 
3.1.3 Correlation among traits 
Phenotypic correlations were computed in order to assess the co-variation among the muscle-related 
traits. Traits with high correlations may show similar results from the subsequent association analyses. 
All analyses were done overall and within European Americans and African Americans. The highest 
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phenotypic correlations were between KCTMAX, TOTLEAN, and THMUS (Table 7).The correlations 
between KCTMAX and TOTLEAN, KCTMAX and THMUS, and TOTLEAN and THMUS were 0.72, 0.75 and 
0.90 (all p-value < 00001), respectively. THIMF and THMUSD were significantly, but negatively correlated 
(r=-0.61, p< 0.0001). Although significant, correlations between the remaining phenotypes were 
moderate and low. The phenotypic correlations among muscle-related phenotypes for European 
Americans and African Americans were similar (Table 8 and Table 9), however, overall correlations were 
higher for European Americans. In African Americans, correlations between THIMF and THMUSD, 
THMUS-KCTMAX, THMUS-TOTLEAN, and KCTMAX-TOTLEAN were 0.61, 0.70, 0.87, and 0.634, 
respectively (all p-value <0.0001). Similarly, in European Americans, correlations between THIMF-
THMUS, THMUS-KCTMAX, THMUS-TOTLEAN, and KCTMAX-TOTLEAN were 0.60, 0.79, 0.92, and 0.77, 
respectively (all p-value <0.0001). 
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Table 7: Phenotypic correlations (r) among muscle-related traits (transformed and adjusted for 
significant covariates) 
Correlations 
 logTHIMF sqrtTHMUS sqrtTHMUSD sqrtKCTMAX sqrtTOTLEAN numericTOTPF 
logTHIMF 
 1 .214 -.614** .039** .275* .465** ** 
Sig. (2-tailed)  .000 .000 .046 .000 .000 
       
sqrtTHMUS 
 . 1 .061 .746** .901** -.418** 
Sig. (2-tailed) 
** 
  .001 .000 .000 .000 
       
sqrtTHMUSD 
   1 .205 .015 ** -.505
Sig. (2-tailed) 
** 
   .000 .422 .000 
       
sqrtKCTMAX 
    1 .716 -.464** 
Sig. (2-tailed) 
** 
    .000 .000 
       
sqrtTOTLEAN 
     1 -.415
Sig. (2-tailed) 
** 
     .000 
       
numericTOTPF 
      1 
Sig. (2-tailed)       
       
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Table 8: Phenotypic correlations (r) among muscle- related traits (transformed and adjusted for   
significant covariates) in European Americans 
  logTHIMF sqrtTHMUS sqrtTHMUSD sqrtKCTMAX sqrtTOTLEAN numericTOTPF 
 
        
 
 
      
        
logTHIMF 
  1 .215 -.603** .102** .287** .421** ** 
Sig. (2-
tailed) 
 
 
.000 .000 .000 .000 .000 
        
sqrtTHMUS 
   1 .044 .791 .922** -.484** ** 
Sig. (2-
tailed) 
  
 
.064 .000 .000 .000 
        
sqrtTHMUSD 
    1 .155 .001 ** -.488** 
Sig. (2-
tailed) 
   
 
.000 .981 .000 
        
sqrtKCTMAX 
     1 .773 -.493** ** 
Sig. (2-
tailed) 
    
 
.000 .000 
        
sqrtTOTLEAN 
      1 -.479** 
Sig. (2-
tailed) 
     
 
.000 
        
numericTOTPF 
       1 
Sig. (2-
tailed) 
.      
 
        
**. Correlation is significant at the 0.01 level (2-tailed). 
a. RACE = European 
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Table 9: Phenotypic correlations (r) among muscle- related traits (transformed and adjusted for 
significant covariates) in African Americans 
  logTHIMF sqrtTHMUS sqrtTHMUSD sqrtKCTMAX sqrtTOTLEAN numericTOTPF 
 
        
 
 
      
        
logTHIMF 
  1 .138 -.610** -.048 ** .235 .522** ** 
Sig. (2-
tailed) 
 
 
.000 .000 .121 .000 .000 
        
sqrtTHMUS 
   1 .139 .706** .876** -.375** ** 
Sig. (2-
tailed) 
  
 
.000 .000 .000 .000 
        
sqrtTHMUSD 
    1 .280 .059** -.523* ** 
Sig. (2-
tailed) 
   
 
.000 .038 .000 
        
sqrtKCTMAX 
     1 .634 -.435** ** 
Sig. (2-
tailed) 
    
 
.000 .000 
        
sqrtTOTLEAN 
      1 -.355** 
Sig. (2-
tailed) 
     
 
.000 
        
numericTOTPF 
       1 
Sig. (2-
tailed) 
.      
 
        
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
a. RACE = African 
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3.2      SINGLE SNP-SINGLE TRAIT ASSOCIATION RESULTS 
The single SNP-single trait association analyses were performed using PLINK in the European American 
and African American cohort separately. Although a total of 1735 SNPs from 27 genes were initially 
available, 221 SNPs were excluded in African Americans and 109 SNPs were in European Americans due 
to low minor allele frequencies (MAF<0.05). A summary of the most significant results are given in Table 
8 and 9. As described above, based on the number of tests, a significant result required p ≤ 5×10-5.  In 
Figures 5-16, the -log10
Although no SNPs achieved experiment wide significance, several genes had multiple SNPs that 
were associated with a muscle-related trait at p<0.01. To investigate these results further, I tallied the 
number of SNPs within each gene had p-values 10
p-value for each SNP in each gene is plotted for each trait. The SNPs are plotted 
by chromosome and base-pair position, and the horizontal line marks p= 0.01. As can be seen from 
Figures 3.5-3.16, none of the SNPs achieved experiment-wide significance with any trait in either 
European or African Americans. The most significant association (P <0.00015) was between SNP 
(rs805554) in RALGABP and TOTPF in African Americans (Figure 15 and Table 10). 
-2
 
 for each trait in European Americans and African 
Americans and also listed the most significant p- value for each gene(Table 10 and 11). Although several 
genes contained SNPs that were associated (at p< 0.01) with several traits, there was no overlap 
between European American and African American results. That is, the same SNPs did not affect the 
same traits in the two groups. In the next few sections, I will discuss results in each ancestry group 
separately. 
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Figure 5: Plot of –(log10p-value) and location (in bp) for KCTMAX                         Figure 6:Plot of –(log10
 
p-value) and location (in bp) for KCTMAX 
 
Figure 7: Plot of –(log 10p-value) and location (in bp) for TOTLEAN in AA          Figure 8: Plot of –(log10
 
p-value) and location (in bp) for TOTLEAN in EA 
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Figure 9: Plot of –(log 10p-value) and location (in bp) for THMUS in AA              Figure 10: Plot of –(log10
 
p-value) and location (in bp) for THMUS in EA 
 
Figure 11: Plot of –(log10p-value) and location (in bp) for THMUSD in AA                        Figure 12: Plot of –(log10
 
p-value) and location (in bp) for THMUSD in EA 
Figure 13: Plot of –(log 10p-value) and location (in bp) for THIMF  in AA                    Figure 14: Plot of –(log 10p-value) and location (in bp) for THIMF in EA 
 
 
28 
 
 
Figure 15: Plot of –(log 10p-value) and location (in bp) for TOTPF in AA             Figure 16:Plot of –(log10
 
p-value) and location (in bp) for TOTPF in EA 
3.2.1 Association Results in European Americans 
In European Americans, there was minimal clustering of associations within genes or across traits (Table 
10). However, three SNPs (#rs11053877, #rs10845181, and #rs1026462) within MAGOHB locus on 
chromosome 12 are associated with THIMF (p= 3.062×10-3, 8.433×10-3, and 2.282×10-3, respectively). In 
addition, 2 of these SNPs (#rs1026442 and #11053877, p= 2.237×10-3 and 2.582×10-3
 
, respectively) were 
associated with variation in thigh muscle density (THMUSD) and 1 SNP (rs12811247) was associated with 
total percent fat (TOTPF). These three traits are moderately correlated with each other (see table 7 and 
table 8: Phenotypic Correlations). These results may indicate that variation in MAGOHB has pleiotropic 
effects on multiple traits. There was no apparent clustering among the remaining results with p-values 
<0.01. 
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Table 10:  Genes with SNP associations p < 10-2
 
  by trait in European Americans 
TRAITS                            
                                
                               Total                                Total                                                           Total                                                            Total 
             
GENE 
 KCTMAX SNPs 
(#sig) 
THIMF SNPs 
(#sig) 
THMUS THMUSD SNPs 
(#sig) 
TOTLEAN TOTPF      SNPs 
(#sig) 
            
      
MAGOHB 
 -  2.8×10 46(3) -3 - 2.2×10 46(2) -3 - 9.7×10 46(1) -3 
      MVK  4.8×10 32(1) -3 -  - -  - -  
     NPC1  -  3.1×10 40(2) -3 - -  - -  
    SLC27A4  -  -  - 3.3×10 9(2) -3 - -  
              
              
 
3.2.2 Association Results in African Americans 
In African Americans, there were several clusters of p-values within genes and across traits (Table 11). 
As mentioned above, a SNP (rs805554) located in RALGAPB (KIAA1219) is significantly associated with 
total percent fat (TOTPF) in African Americans (p value= 1.517×10-4). RALGAPB (is on chromosome 20 
and codes for the Ral GTPase activating protein, beta subunit (non-catalytic).Five additional SNPs 
(rs1115600, rs1295992, rs12625459, rs805559, and rs805552) in RALGAPB are also associated with 
TOTPF (p= 8.404×10-3, 5.133×10-3, 3.33×10-3, 5.305×10-3, and 4.658×10-3
 
 , respectively). In addition, eight 
SNPs (rs2185594, rs805554, rs130577, rs1315305, rs1303571, rs11699660, rs41812025, and rs2206783 
in the RALGAPB locus are associated with thigh intermuscular fat, of which rs805554 is the same as the 
associated with total percent fat. Finally, two SNPs (rs9941745 and rs9941761) in the RALGAPB locus are 
associated with total lean mass.  
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Table 11: Genes with SNP associations p < 10-2 
 
by trait in African Americans 
 TRAITS  
Total 
  
Total 
  
Total 
  
Total 
  
Total 
 
 
 
Total 
GENE  KCTMAX SNPs 
(#sig) 
THIMF SNPs 
(#sig) 
THMUS SNPs 
(#sig) 
THMUSD SNPs 
(#sig) 
TOTLEAN SNPs 
(#sig) 
TOTPF SNPs 
(#sig) 
ADCK3  9.9×10  -3 -  -  -    -  
COQ2  -  -  5.4×10 15(1) -3 -    -  
CYP3A5  -  4.7×10 25(1) -3 -  6.5×10 24(1) -3   1.3×10 27(3) -3 
FDPS  3.5×10 7(2) -3 -  -  -    -  
GOLGA4  -  -  -  -    2.4×10 68(6) -3 
JUP  -  -  -  -  8.0×10 23(1) -3 -  
MAGOHB  -  -  2.5×10 62(1) -3 -  3.4×10 59(1) -3 -  
MVK  -  -  1.8×10 26(1) -3 -    -  
NPC1  -  -  -  -    4.2×10 59(4) -3 
PDSS1  -  8.7×10 63(3) -3 -  -    8.2×10 70(2) -3 
RALGABP  -  3.1×10 81(6) -3 -  -  4.1×10 91(2) -3 1.5×10 84(6) -4 
SAC1ML  8.5×10 75(1) -3 -  -  -    -  
              
 
            Variation in total percent fat (TOTPF) in African Americans was also associated with SNPs in other 
genes including: (1)  four SNPs (rs1652344, rs1631685, rs1652348, and rs1788781)  within the NPC1 
locus on chromosome 18 (p=8.776 ×10-3, 7.433 ×10-3, 6.498 ×10-3, and 4.256 ×10-3, respectively); (2)  six 
SNPs (rs6800842 , rs11129756, rs6550470, rs7639447, rs4635655, and rs17266090) in the GOLGA4 locus 
on chromosome 3 (p= 5.149×10-3, 2.606×10-3, 2.438×10-3, 2.528×10-3, 2.488×10-3, and 4.71×10-3, 
respectively); and (3) three SNPS (#rs10242455, # rs4646457, and # rs776746) in the CYP3A5 locus on 
chromosome 7 (p= 1.325×10-3, 5.09×10-3, and 5.395×10-3, respectively).  Of particular interest, 
genotypes at SNP rs10242455 in CYP3A5 were also associated with both thigh intermuscular fat (p= 
4.768×10-3) and thigh muscle density (p=6.564×10-3). Thus, this latter SNP may have pleiotropic effects 
on multiple traits. 
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SNPs in additional loci were associated (P< 0.01) with other muscle-related traits, but there 
were no apparent clusters among the remaining results.  
 
3.3 LINKAGE DISEQUILIBRIUM AND MEAN EFFECTS OF SNPS IN GENES OF INTEREST 
As described previously, single SNP-single trait analysis revealed several loci associated with specific 
phenotypes within each ancestry cohort, although none of these results achieved experiment-wide 
significance. However, to further assess the strength of some of the associations, I plotted regional 
significant association results from single gene-single trait association results using the LocusZoom 1.1 
tool (Pruim RJ, 2010). LocusZoom provides visual display of regional strength association information 
based on genomic position, local linkage disequilibrium (LD), recombination hotspots and the gene 
positions in the significant regions.  Estimates of recombination and LD are obtained from HapMap. 
According to Loos, SNPs within a gene that are several hundred kb may be still correlated to each other 
(Loos et al., 2008). Thus, multiple significant SNP associations may be due to one or a few ‘true’ signals. 
In addition, for specific SNP-trait pairs, genotypic means were calculated and phenotype by genotype 
box-plots were created to assess the effect of the variant on the specific muscle-related trait. 
3.3.1 MAGOHB in European Americans 
In European Americans, multiple SNPs within MAGOHB were associated with thigh intermuscular fat, 
thigh muscle density, and total percent fat.  Figure 17 is a plot of the physical position of all tested SNPs 
within this chromosomal region by the –log10p values for association with thigh intermuscular fat 
(THIMF). Recombination hotspots (blue solid line) are at 10.63 Mb and 10.68 Mb. The purple diamond 
represents the SNP with the lowest p value (rs1026442). The colors of the other SNPs represent their 
correlation with the most significant SNP. Yellow circle shows the 0.6 < r2 < 0.8 and green circle shows 
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the 0.4 < r2 < 0.6. Blue circle shows the 0.2 < r2
 
 < 0.4. As can be seen, the two SNPs with the most 
significant p-values, rs1026442 (purple diamond) and rs11053877 (red circle) are in high LD with each 
other. Thus, although these SNPs are 10.37kb apart, the significant associations with THIMF and 
THMUSD likely represent the same “true” signal. In addition, other SNPs within MAGOHB and KLRA1 
show no evidence for association and are not correlated with the two most significant SNPs. 
 
Figure 17:  Association between THIMF and SNPs around MAGOHB (rs1026442) on 12p13.2 in European Americans 
 
I next calculated the means of thigh muscle density (THMUSD) and intermuscular fat (THIMF) by 
each genotype for two SNPs in MAGOHB: rs11053877 and rs1026442 (Table 12). In the tables below, 
“22” represents the homozygote of the minor allele, “12” is the heterozygote, and “11” is the 
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homozygote of the major allele for each locus.  The minor allele frequencies of both loci are similar and 
as can be seen in Table 12, the genotypic means of these two loci are similar for each trait. For example, 
for rs1026442, the mean of THIMF (using the residuals of the transformed data) for the homozygote (22) 
for the minor allele is higher than that of the other homozygote (11), whereas the mean of the 
heterozygote is closer to that of the minor allele homozygote mean. A similar effect is seen for 
rs11053877, that is, the minor allele genotype at each locus seems to have a recessive effect on THIMF.  
In contrast, for THMUSD, the mean of the homozygote (22) of the minor allele for rs1026442 is lower 
than the means of the other homozygote and the heterozygote man is intermediate.  The results for 
rs11053877 are similar.  Thus, for THMUSD, there appears to be more of a dosage effect of the minor 
allele. The genotypic effects of SNPs (rs1026442 and rs11053877) on the two traits are also illustrated 
using box and whisker plots (Figure 18, Figure 19, Figure 20, and Figure 21). 
 
Table 12:  Means (±s.e.) of Muscle-related traits (transformed and adjusted for covariates) by SNP 
genotypes in MAGOHB in European Americans 
 
  SNP 
 Genotype rs1026442 rs11053877 
Alleles  A/G A/G 
MAF  0.1926 0.1939 
    
THIMF 11 -0.03±0.01  -0.03±0.01 
 12 0.05±0.02 0.06±0.02 
 22  0.04±0.06 0.04±0.06 
THMUSD 11 0.03±0.01 0.03±0.01 
 12 -0.05±0.02 -0.05±0.02 
 22  -0.08±0.07 -0.09±0.07 
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Figure 18: The genotype-THIMF plot of rs1026442                   Figure 19: The genotype-THMUSD plot of rs1026442 
                                                             
Figure 20: The genotype-THIMF plot of rs11053877                                       Figure 21: The genotype-THMUSD plot of rs11053877 
 
3.3.2 RALGAPB in African Americans 
In African Americans, multiple SNPs within RALGPB were associated with thigh intermuscular fat, total 
lean, and total percent fat. Figure 22 is a plot of the physical position of all tested SNPs within this 
chromosomal region by the –log10p values for association with total percent fat (TOTPF) using SNP 
rs805554 and rs805552 as the index SNPs. A similar result was obtained for association with thigh 
intermuscular fat (THIMF), so I just present the results for total percent fat (TOTPF). As can be seen, 
multiple SNPs across the RALGAPB locus are associated with the TOTPF. However, when rs805554 is 
used as the index SNP, several SNPs are not in high LD with this SNP which could indicate that variation 
 
 
35 
 
in more than one region of RALGAPB may influence the muscle-related traits. Although the “true” causal 
variant or region is not clear, when rs805552 is used as the index SNP, 4 SNPs across the gene are in high 
LD with the index SNP (These two SNPs are 4.234 kb apart from each other). These results may indicate 
that variation in possibly two regions within RALGAPB influence muscle-related traits. Figure 23 is a plot 
of the physical position of all tested SNPs within this chromosomal region by the –log10
 
p values for 
association with total lean (TOTLEAN) using SNP rs9941761 as the index SNP. When rs9941761 (which is 
near the 3’ end of RALGABP) is used as the index SNP, two SNPs across the gene are in high LD with the 
index SNP and one of these SNPs is near the middle of RALGABP. From all of these  results it is not clear 
whether there is more than one ‘true’ signal for RALGABP, nor is it clear where the signal might be 
located.  
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Figure 22: Association between TOTPF and SNPs near RALGBP in African Americans using SNPs rs805554 and    
rs805552 as the index SNP. 
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Figure 23: Association between TOTLEAN and SNPs near RALGBP in African Americans using SNPrs9941761 as the index SNP. 
 
I next calculated the means of thigh intermuscular fat (THIMF), and total percent fat (TOTPF) by 
each genotype for rs805554 SNP in RALGAPB. (Table 13). As can be seen, the means of TOTPF and 
THIMF for the homozygote for the minor allele (22) are higher than the other homozygote (11), whereas 
the mean of the heterozygote is in between. Thus, there appears to be a dosage effect of the minor 
allele on each trait. The genotypic effects of SNP rs805554 on the TOTPF and THIMF are also illustrated 
using box and whisker plots (Figure 24 and Figure 25). 
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Table 13:  Means (±s.e.) of Muscle-related traits (transformed and adjusted for covariates) by SNP 
genotypes in RALGAPB in African Americans 
 
 
  
  
 
Figure 24: The genotype-TOTPF box-plot(rs 805554)                                          Figure 25: The genotype-THIMF box plot(rs805554) 
 
3.3.3 CYP3A5 in African Americans 
In African Americans, multiple SNPs within CYP3A5were associated with thigh intermuscular fat (THIMF), 
thigh total muscle density (THMUSD), and total percent fat (TOTPF).  Figure 26 is a plot of the physical 
position of all tested SNPs within this chromosomal region by the –log10p values for association with 
total percent fat (TOTPF) using SNP rs10242455 as the index SNP.  When rs10242455 (which is in the 3’ 
  SNP 
 Genotype rs805554 
Alleles  A/T 
MAF  0.1307 
   
TOTPF 11 -27.22±13.86 
 12 82.30±26.19 
 22 120.62±87.12 
THIMF 11 -0.02±0.02 
 12 0.07±0.03 
 22 0.19±0.10 
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UTR) is used as the index SNP, 2 SNPs across the gene are in high LD with the index SNP, one of which is 
near the 5’ end.  These results may indicate that variation in possibly this region within CYP3A5 
influences muscle-related traits, although the location of a ‘true’ causal variant is unclear. 
 
Figure 26: Association between THIMF and SNPs near CYP3A5 in African Americans using SNP rs10242455 as the index SNP. 
 
I also calculated the means of thigh THIMF, THMUSD and total percent fat by each genotype for 
three SNPs in CYP3A5: rs10242455 (Table 14). As can be seen, the means of THIMF and TOTPF for the 
homozygote (22) for the minor allele is lower than those of the other homozygote, whereas the means 
of the heterozygote are in between. On the other hand, the mean of THMUSD for the homozygote (22) 
for the minor allele is higher than those other homozygote (11), whereas the mean of heterozygote is in 
between. Again, the minor allele has a dosage effect of the traits. The genotypic effects of rs10242455 
SNP on these traits is consistent with the phenotypic correlation among these traits (see Table 5). That 
is, the minor allele is associated with a decrease in TOTPF and THIMF, but is associated with an increase 
in THMUSD. The genotypic effects of SNPs (rs10242455) on the TOTPF, THIMF, and THMUSD are also 
illustrated using box and whisker plots (Figure 27, Figure 28, and Figure 29). 
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Table 14:  Means (±s.e.) of Muscle-related traits by SNP genotypes in CYP3A5 in African Americans 
  SNP 
 Genotype rs10242455 
Alleles  A/G 
MAF  0.3143 
THIMF 11 0.04±0.02 
 12 -0.03±0.02 
 22 -0.09±0.04 
THMUSD 11 -0.04±0.02 
 12 0.02±0.02 
 22 0.10±0.04 
TOTPF 11 36.33±18.07 
 12 -20.30±18.82 
 22 -83.22±33.59 
 
 
 
Figure 27: Genotype-THIMF box plot(rs10242455)                                          Figure 28: Genotype-THMUSD box plot(rs10242455) 
 
 
  Figure 29: Genotype-TOTPF box-plot(rs10242455) 
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 3.3.4 GOLGA4 in African Americans 
In African Americans, multiple SNPs within GOLGA4 were associated with thigh total percent fat 
(TOTPF). Figure 30 is a plot of the physical position of all tested SNPs within this chromosomal region by 
the –log10
 
p values for association with total percent fat (TOTPF) using SNP rs6550470 as the index SNP.  
When rs6550470 is used as the index SNP, 2 SNPs across the gene are in high LD with the index SNP, but 
others are not. These results may indicate that variation in possible multiple regions within GOLGA4 
influences muscle-related traits. 
 
Figure 30: Association between TOTPF and SNPs near GOLGA4 in African Americans using SNP rs6550470 as the index SNP. 
              
Lastly, I calculated the mean of TOTPF by each genotype for the SNPs rs6550470 which is the 
most significant SNP with the p value 2.438×10-3 in GOLGA4. As can be seen, the mean of TOTPF for the 
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homozygote(22) for the minor allele is higher than those of the other homozygote(11), whereas the 
mean of the heterozygote is in between, showing that increasing dosage of the minor allele is associated 
with increasing TOTPF.  (Table 15). 
Table 15: Means (±s.e.) of TOTPF (transformed and adjusted for covariates) by SNP genotypes in 
GOLGA4in African Americans 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  SNP 
 Genotype Rs6550470   
Alleles  A/G   
MAF  0.446   
TOTPF 11 -41.11±30.17   
 12 -2.02±16.23   
 22 72.01±23.26   
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4.0 DISCUSSION 
 
Advancing age results in major changes in body composition, including decreases in skeletal and muscle 
mass. Sarcopenia, the loss of muscle mass and strength that occurs with aging, plays a crucial role in 
frailty and results in increased morbidity and mortality among older individuals. The loss of muscle mass 
and function varies greatly among older individuals, however the underlying causes and mechanisms of 
this variation are unclear. Because sarcopenia and measures of muscle mass and strength are heritable, 
many genetic studies, including large genome-wide association consortium studies, have been done to 
identify genes that influence traits related to sarcopenia, such as total lean mass and obesity (e.g., BMI). 
These studies have identified several genes that influence lean mass and BMI, but these genes do not 
account for all of the known heritability of the trait.  In addition, few studies have been performed in 
older individuals or using traits more strongly associated with sarcopenia, such as muscle function and 
muscle density. In order to better understand the genetic basis of sarcopenia, I performed the single 
SNP-single trait association analysis using genotype data on 778 SNPs in 27 candidate genes and 
phenotype data on 6 measures of muscle function and density (KCTMAX, TOTLEAN, TOTPF, THIMF, 
THMUS and THMUSD) from 3075 men and women aged 70-79 years in the HealthABC cohort. The 
muscle density measures of THIMF, THMUS, and THMUSD were calculated as the average of the 
measurements from left and right thigh. Analyses were performed separately in the European American 
(n=1794) and African American (n=1281) cohorts separately. 
 Overall, none of the associations in either ancestral group achieved the experiment-wide 
significance level (p<10-5).  The most significant result was an association In African Americans between 
total percent fat and SNPs in the RALGAPB locus (minimum p-value = 1.5×10-4). I further investigated all 
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tests that achieved a more liberal significance level (p-value < 10-2). Interestingly, even at this more 
liberal significance level, there was minimal overlap in results from analyses in the European Americans 
versus African American cohorts; only three genes showed an association <10-2
 Although none of the results were statistically significant at the experiment-wise level, several 
associations were potentially interesting and I discuss two of these in more detail below.  
 in both cohorts 
(MAGOHB, MVK, and NPC1) but the associations were between different SNPs and different traits 
(Tables 10 and 11). This result indicates that at least some of the variation in these muscle-related traits 
is influenced by different genes between the two groups. Such an observation is not surprising because 
of known phenotypic and genetic differences in body composition traits between individuals of 
predominantly African versus European ancestry (Shaffer, 2007; Goodpaster, 2002). 
4.1 ASSOCIATION WITH RALGAPB 
One of most promising results was the association in African Americans between multiple SNPs within 
RALGAPB locus in African Americans and variation in total percent fat, thigh intermuscular fat, and total 
lean mass. The genomic location of RALGAPB in humans is on 20q11.23. The LD between two SNPs, 
rs805554 and rs805552, with the most significant association results is high and equals 0.797. These 
SNPs are also in moderate to high LD (0.6 < r2 < 0.9) with other associated SNPs in RALGAPB (Figure 22).  
Because the LD among all of the SNPs is not uniformly high (e.g, LD>0.80), it is not clear whether one or 
more variants potentially influence variation in total percent fat, thigh intermuscular fat, or total lean 
mass. Furthermore, it is not clear where in RALGAPB the potentially ‘causal’ variants are located because 
associated SNPs are located across the gene.  Both SNP rs805554 (T>A) and SNP rs805552 (C>G) are 
located in the intron 1 region of RALGAPB, and are unlikely to be causal. Variants in introns can have 
causal effects because introns have many short sequences which are significant in effective splicing. 
Acceptor and donor sites at both ends of the intron are important in proper splicing. It was found that 
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introns affect the expression level of host gene (Chorev 2012). Introns also enhanced the gene 
expression by intron-mediated enhancement (Jonsson,1992). However, we do not know whether these 
two SNPs are causal or whether they are in high LD with another, unassayed but causal variant. 
The two most significant SNPs in RALGAPB  were associated with variation in total percent fat 
and thigh intermuscular fat. Total percent fat and total intermuscular fat have a phenotypic correlation 
(r) equal to 0.47 (r2
RALGAPB, the homolog of KIAA1219, is a Ral GTPase activating protein, beta subunit (non-
catalytic) and is a non-catalytic subunit of the heterodimeric RalGAP1 and RalGAP2 complexes that act 
as GTPase activators for the Ras-like small GTPases RALA and RALB. RALGAPB gene is the homolog of a 
putative gene D.2085.5 that is located on chromosome II of C.elegans. How variation in RALGAPB may 
influence muscle-related traits (and sarcopenia) is unclear. However, a RalGAP complex is involved in 
insulin–stimulated glucose trafficking in muscle and adipose tissue (Chen et al., 2011). As stated earlier, 
insuin-signalling pathways are associated with longevity, thus the involvement of Ral GAP and other 
members of this pathway in insulin signaling makes it a reasonable candidate for future study. 
Furthermore, another member of this pathway, the Ras-like small G protein, RalB, may be involved in 
the activation of the autophagosome in the presence of nutrient deprivation (Bodemann, et al. 2011). 
Thus, further study of this pathway may provide novel insights into the development of sarcopenia. 
 = 0.22). Total lean mass has a positive, but low correlation with thigh intermuscular 
fat (r = 0.28), and a negative, moderate correlation with total percent fat (r = 0.42). The mean effects of 
genotypes at the rs805554 locus on THIMF and TOTPF are consistent with the phenotypic correlation 
among the traits. Thus, the association results may indicate that polymorphisms within RALGAPB have 
pleiotropic effects on the two muscle-related traits. 
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4.2 ASSOCIATION WITH MAGOHB 
Another potentially interesting result is the association with SNPs within MAGOHB locus and thigh 
intermuscular fat, thigh muscle density, and total percent fat in European Americans. The chromosomal 
location of MAGOHB in humans is 12p13.2.   The two SNPs, rs1026442 and rs11053877, with the 
strongest association results are in high LD with each other (LD= 0.97), thus the association between 
SNPs and MAGOHB and the muscle-related traits is likely due to a single, ‘causal’ variant.  However, the 
location of the potentially causal variant is unclear because rs1026442 is located within the first intron 
whereas rs11053877 is located in the 3’ untranslated region. As stated above, variants in introns may 
affect protein function and expression. Furthermore, 5' UTR and 3' UTR have roles in mRNA stability, 
translational efficiency and mRNA localization. 3' UTR influences regulation of transcript stability (Laroia 
1999). In addition, SNPs on 3' UTR
Both SNPs in MAGOHB were associated with variation in two correlated traits: THIMF and 
THMUSD density .Total percent fat and thigh intermuscular fat have a phenotypic correlation (r) equal 
to 0.47 (r
 influence microRNA function (Zihua, 2011). To determine whether 
these associated SNPs may be Causal or whether they are in high LD with an unassayed variant will 
require additional analyses. 
2 = 0.22), whereas thigh intermuscular fat is negatively correlated (r=-0.61) with thigh muscle 
density. The genotypic means of the three traits for SNP rs1026442, rs11053877, and rs12811247 in 
MAGOHB (Table 10) reflect the phenotypic relationship among the traits. Thus, variation in MAGOHB 
likely has pleiotropic effects on the correlated traits. MAGOHB (mago-nashi homolog B) is involved in 
mRNA splicing and in the nonsense-mediated decay (NMD) pathway (Roignant and Treisman, 2010) and 
has not been previously identified as potential candidate genes for development of sarcopenia, although 
control of RNA splicing could definitely have effects on muscle-related traits.  Recent reports also 
indicate that Magoh, as a component of the exon junction complex, regulates division of neural stem 
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cells (Silver et a., 2010). Given the connection between peripheral nerve function and muscle strength 
(Strotmeyer et al, 2009), members of this pathway also are reasonable candidates for further study of 
the development of sarcopenia. 
4.3 CONCLUSION 
To identify genes that may influence development of sarcopenia, I performed association analyses 
between several muscle-related traits and SNPs in 27 candidate genes that were homologs of genes that 
influence the onset of sarcopenia in C. elegans. None of these candidate genes have been associated 
with lean mass or obesity (measured as BMI) in (mostly) middle-aged adults in studies from large 
consortia (http://www.genome.gov/26525384). However, none of the consortia studies have identified 
all of the genes that influence lean mass and BMI. Furthermore, lean mass and BMI in middle-aged 
adults are only crudely correlated with sarcopenia in older individuals and no large studies of sarcopenia 
or measures of muscle mass and function have been done, especially in older adults. 
Although none of the results of this study were statistically significant at an experiment-wide 
level, several of the results were suggestive.   In particular, variants in MAGOHB may influence fat 
infiltration into muscle among individuals with European ancestry, whereas variants in RALGABP may 
influence fat infiltration among individuals with African ancestry. Neither of these genes, or biological 
pathways, has been previously identified as playing a role in sarcopenia, but further studies may 
potentially lead to novel insights regarding development of sarcopenia. Replication in other populations 
is necessary, as well as additional bioinformatic and mechanistic studies, but these are beyond the scope 
of this thesis. However, these results indicate the potential usefulness of animal models to generate 
hypotheses for further study in men and women. 
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APPENDIX A 
 
PLOTS OF RTHIMF, LTHIMF, RTHMUSD, LTHMUSD, RTHMUS, LTHMUS BY ANCESTRY GROUP 
  
African Americans European Americans 
 
 
Figure A1:Plot of -log10 Figure A2:Plot of -logp and bp for LTHIMF in African Americans 10p and bp for LTHIMF in European Americans 
 
 
Figure A3: Plot of -log 10
 
p and bp for RTHIMF in African Americans Figure A4:Plot of-log10
 
p and bp for RTHIMF in European Americans 
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Figure A5: Plot of -log 10 Figure A6 :Plot of –logp and bp for LTHMUS in African Americans 10p and bp for LTHMUSD in European 
Americans 
 
  
Figure A7:Plot of -log10 Figure A8:Plot of –logp and bp for RTHMUS in African Americans 10p and bp for RTHMUSD in European 
Americans 
  
Figure A9: Plot of -log 10 Figure A10:Plot of –logp and bp for LTHMUSD in African Americans 10p and bp for LTHMUS in European 
Americans 
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Figure A11:Plot of -log10 Figure A12:Plot of –logp and bp for RTHMUSD in African Americans 10p and bp for RTHMUS in European 
Americans 
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APPENDIX B 
 
HISTOGRAMS OF TRAITS 
  
  
  
Figure B1: Histogram of THMUS Figure B2: Histogram of sqrtTHMUS 
  
Figure B3: Histogram of THMUSD Figure B4 :Histogram of sqrtTHMUSD 
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Figure B7: Histogram of TOTLEAN Figure B8: Histogram of sqrtTOTLEAN 
 
 
Figure B9: Histogram of RTHIMF Figure B10: Histogram of sqrtRTHIMF 
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Figure B11: Histogram of LTHIMF Figure B12: Histogram of loqLTHIMF 
 
 
Figure B13: Histogram of  RTHMUS Figure B14: Histogram of sqrtRTHMUS 
 
 
Figure B15: Histogram of LTHMUS Figure B16: Histogram of sqrtLTHMUS 
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Figure B17: Histogram of RTHMUSD Figure B18: Histogram of sqrtRTHMUSD 
 
 
Figure B19: Histogram of LTHMUSD Figure B20: Histogram of untransformed LTHMUSD 
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APPENDIX C 
 
LOCUS PLOTS OF PHENOTYPES 
 
 
 
  
Figure C1 : Association between THIMF and SNPs around RALGAPB ( 
rs2185594) on 20q11.13 in African Americans 
 
Figure C2: Association between TOTPF and SNPs around GOLGA4( 
rs6550470) on 3p22.2 in African Americans 
  
 
Figure C3: Association between THMUS and SNPs around MAGOHB 
(rs7957619) on 12p13.2 in African Americans 
 
Figure C4: Association between THMUSD and SNPs around MAGOHB 
(rs11053877) on 12p13.2 in European Americans 
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APPENDIX D 
 
RELATIONSHIP BETWEEN TRAITS AND AGE 
 
 
 
Figure D1: Relationship between KCTMAX and AGE (blue=M, red=F) Figure D2: Relationship between RTHIMF and AGE(blue=M, red=F) 
 
 
Figure D3: Relationship between LTHMUS and age(blue=M, red=F) Figure D4: Relationship between LTHIMF and age(blue=M, red=F) 
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Figure D6: Relationship between RTHMUS and age(blue=M, red=F) Figure D7: Relationship between RTHMUSD and age(blue=M, red=F) 
 
 
Figure D8: Relationship between LTHMUSD and age(blue=M, red=F) Figure D9: Relationship between TOTLEAN and age(blue=M, red=F) 
 
 
Figure D10: Relationship between TOTPF and age(blue=M, red=F)  
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APPENDIX E 
 
RELATIONSHIP BETWEEN TRAITS AND RACE 
  
Figure E1: Relationship between KCTMAX and race,green=M,purple=F Figure E2: Relationship between TOTPF and race ,green=M,purple=F 
 
 
Figure E3: Relationship between RTHIMF and race ,green=M,purple=F Figure E4: Relationship between LTHIMF and race green=M,purple=F, 
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Figure E5: Relationship between RTHMUS and race,green=M,purple=F Figure E6: Relationship between LTHMUS and race green=M,purple=F, 
 
 
Figure E7: Relationship between RTHMUSD and 
race,green=M,purple=F 
Figure E8: Relationship between LTHMUSD and race, 
green=M,purple=F 
 
 
Figure E9: Relationship between TOTLEAN and race 
green=M,purple=F, 
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APPENDIX F 
 
GENOTYPE-PHENOTYPE BOX AND WHISKER PLOTS IN EUROPEAN AMERICANS 
  
Figure F1: Genotype-KCTMAX box plot(rs10850436)                              Figure F2: Genotype-THIMF plot(rs1805081) 
  
Figure F3: Genotype-THIMF plot(rs1808579)                                                            Figure F4: Genotype-THIMF plot(rs10845181) 
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Figure F5: Genotype-THIMF plot(rs11053877)                                                     Figure F6: Genotype-MTHMUSD plot(rs1026442) 
 
  
Figure F7: Genotype-THMUSD plot(rs7852856)                                               Figure F8: Genotype-THMUSD plot(rs7869223) 
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APPENDIX G 
 
GENOTYPE-PHENOTYPE BOX AND WHISKER PLOTS IN AFRICAN AMERICANS 
  
Figure G1: Genotype-KCTMAX plot(rs11264359)                                          Figure G2: Genotype-THIMF plot(rs17801180) 
  
Figure G3: Genotype-THIMF plot(rs2185594)                                                       Figure G4: Genotype-THMUS plot(rs7957619) 
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Figure G5: Genotype-TOTLEAN plot(rs11053877)                                   Figure G6: Genotype-TOTPF plot(rs805554) 
  
Figure G7: Genotype-TOTPF plot(rs2185594)                                              Figure G8: Genotype-TOTPF plot(rs1788781) 
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APPENDIX H 
 
SNPS WITH SUGGESTIVE P VALUES IN EUROPEAN AMERICANS 
 
Ancestry 
Gene SNP Location MAF Allele Associated 
Trait 
beta pvalue 
European MAGOHB rs1026442 Intron1 0.19 A/G THIMF -0.0722 2.822×10-3 
    0.19  A/G THMUSD 0.0755 2.582×10-3 
  rs10845181 Intron 1 0.49 C/T THIMF 0.0191 8.433×10-3 
  rs11053877 3’ UTR 0.19 A/G THIMF 0.0721 3.062×10-3 
    0.19 A/G THMUSD -0.0771 2.237×10-3 
  rs12811247 Intron 1 0.46 G/T TOTPF 33.3603 0.714×10-3 
         
 MVK rs10850436 Intron 1 0.26 A/C KCTMAX 0.1479 4.848×10-3 
         
 NPC1 rs1808579 intron 0.45 C/T THIMF 0.0498 7.924×10-3 
  rs1805081 exon 0.39 C/T THIMF -0.0570 3.174×10-3 
 SLC27A4 rs7869223 Intron 1 0.10 C/G THMUSD -0.0923 3.41×10-3 
  rs7852856 Intron 1 0.10 A/T THMUSD -0.0923 3.324×10-3 
 
 
65 
 
 
APPENDIX G 
 
SNPS WITH SUGGESTIVE P VALUES IN AFRICAN AMERICANS 
Ancestry Gene SNP Location MAF Allele Associated 
Trait 
beta pvalue 
African ADCK3 rs2077734 Intron1 0.13 G/T KCTMAX -0.2598 9.976×10-3 
 COQ2 rs4693597 Intron 1 0.28  C/T THMUS -0.1307 5.402×10-3 
 CYP3A5 rs10242455 intron 0.31 A/G THIMF -0.0743 4.768×10-3 
    0.31 A/G THMUSD 0.0742 6.564×10-3 
    0.31 A/G TOTPF -59.2917 1.325×10-3 
  rs4646457 intron 0.32 A/C TOTPF -51.0726 5.09×10-3 
  rs776746 Intron-
variant 
0.33 C/T TOTPF -50.7495 5.395×10-3 
 FDPS rs3020781 intron 0.42 A/G KCTMAX 0.1855 5.649×10-3 
 GOLGA4 rs6800842 intron 0.47 A/G TOTPF 50.0047 5.149×10-3 
  rs11129756 intron 0.44 A/G TOTPF 54.5200 2.606×10-3 
  rs6550470 intron 0.44 A/G TOTPF -54.8735 2.438×10-3 
  rs7639447 intron 0.42 C/T TOTPF 18.2568 2.528×10-3 
  rs4635655 intron 0.142 A/G TOTPF 55.3529 2.488×10-3 
  rs17266090 Intron 0.47 A/G TOTPF -50.7139 4.71×10-3 
 JUP rs9914318 intron 0.25 C/T TOTLEAN 2.0862 8.07×10-3 
 MAGOHB rs10746384 intron 0.14 A/G THMUS 0.1763 2.568×10-3 
  rs11053877 3’ UTR 0.09 A/G TOTLEAN 3.2678 3.407×10-3 
 NPC1 rs1652344 intron 0.27 C/T TOTPF -50.7536 8.776×10-3 
  rs1631685 intron 0.27 C/T TOTPF 51.8288 7.433×10-3 
  rs1652348 intron 0.27 C/T TOTPF 52.7439 6.498×10-3 
  rs1788781 intron 0.27 C/T TOTPF 19.2749 4.256×10-3 
 PDSS1 rs1780179 intron 0.44 C/T THIMF 0.0645 8.747×10-3 
  rs1748357 intron 0.44 A/G THIMF -0.0645 8.747×10-3 
    0.44 A/G TOTPF -45.3115 8.285×10-3 
  rs1780180 intron 0.44 A/G THIMF -0.0646 8.719×10-3 
   intron 0.44 A/G TOTPF -45.3559 8.223×10-3 
 RALGAPB rs9941745 intron 0.09 C/T TOTLEAN -3.3229 4.439×10-3 
  rs9941761 intron 0.09 C/T TOTLEAN 3.3463 4.158×10-3 
  rs805554 intron 0.13 A/T THIMF 0.0983 9.653×10-3 
   intron 0.12 A/T TOTPF 101.7339 1.527×10-4 
  rs1115600 Intron 1 0.09 G/T TOTPF -98.7616 8.404×10-4 
  rs1295992 intron 0.10 A/G TOTPF -
100.7957 
5.133×10-4 
  rs1262459 exon 0.06 A/G TOTPF -
143.6325 
0.33×10-3 
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  rs805559 intron 0.10 A/G TOTPF 101.4057 5.305×10-4 
  rs805552 intron 0.10 C/G TOTPF -
101.5515 
4.658×10-4 
  rs1303577 exon 0.26 C/T THIMF 0.0730 9.794×10-3 
  rs1315305 intron 0.26 A/C THIMF 0.0730 9.794×10-3 
  rs1303571 intron 0.26 A/G THIMF 0.0739 9.38×10-3 
  rs11699660 intron 0.26 C/G THIMF -0.0734 9.408×10-3 
  rs4812025 intron 0.26 A/G THIMF -0.0768 6.346×10-3 
  rs2185594 intron 0.26 A/G THIMF -0.0834 3.142×10-3 
  rs2206783 intron 0.26 A/G THIMF 0.0733 9.216×10-3 
 SACM1L rs2578677 intron 0.09 C/G KCTMAX -0.3095 8.576×10-3 
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